Clinical Trial: Pegylated Liposomal Doxorubicin (Doxil) With Rituximab in Relapsed AIDS-Related Non-Hodgkin's Lymphomas
Study Status: Terminated
Recruit Status: Terminated
Study Type: Interventional
Official Title: A Pilot Phase II Study of Pegylated Liposomal Doxorubicin (Doxil) With Rituximab in Relapsed AIDS-Related Non-Hodgkin's Lymphomas
Brief Summary: This study is for patients who have been treated before and either the treatment did not work or the lymphoma has come back.
Detailed Summary:
Sponsor: University of Southern California
Current Primary Outcome:
Original Primary Outcome:
Current Secondary Outcome:
Original Secondary Outcome:
Information By: University of Southern California
Dates:
Date Received: September 12, 2005
Date Started: April 2005
Date Completion:
Last Updated: May 20, 2014
Last Verified: May 2006